Evolutive profil and prognosis factors of chronic heart failure in a tunisan center

##plugins.themes.academic_pro.article.sidebar##

Published Dec 26, 2018
Download
pdf
Vol. 96 No. 12 (2018): Issue Dec 2018

##plugins.themes.academic_pro.article.main##

Meriem Drissa
Sana Helali
Yosri Ben Hamida
Habiba Drissa

Abstract

Baground :Therapeutic approach of heart failure (HF) has evolved considerably to improve the prognosis that remains dark .The purpose of our study was to analyze the evolution of the  ejection fraction (FE) heart failure  and to identify predictors  factors of mortality and re-hospitalization.
Methods  Our study is prospective including 200 consecutive cases of HF patients with EF ≤ 40% during the period from 2012 to 2015. Clinical, para-clinical, evolultive  data were collected at admission and atb3 months. The main study  criteria is the occurrence of a major event:  cardiac death and   or rehospitalization for HF.  
Results :The mean age of  our patients was 56 + - 12. with male predominance.  Ischemic etiology was the main causes  (45%). All patients had  pharmacological treatment of HF , 88% patients were put on ACE inhibitors, 91% on beta-blockers(BB)  and 49% on spiranolactone, loop diuretics were prescribed in 95% of cases. The optimal dose was reached for the main molecules (IEC, BB and spiranolactone) only in  respectively  12%, 15% and 10% patients  . Myocardial revascularization was performed in 36 patients (40%). Among  the 45 patients with  valvulopathy   surgical treatment  was indicatetd for   _ patients(17%).  A  cardiac resynchronization theray   with defibrillator  was implanted in 30 patients, an automatic defibrillator without resynchronization was implanted   in 15 patients (7.5%). No patients  from our study  had  a cardiac  transplantation or rehabilitation.Hospital and  3-months  mortality was   5% and 17.5% respectively, .Hospitalization rate was 36% and was highest in the first three months after discharge.  The multi-variable analysis  revealed four independent mortality factors:  diabetes,  EF , ischemic etiology, and TAPSE.  Age, stage IV dyspnea, atrial fibrillation , and SLG <-12.were independent predictors  factors of rehospitalization
Conclusion : is a serious  disease associated   with  poor prognosis despite advanced therapeutics ;

Keywords:

heart failure , echocardiography , prognosis , Tunisia

##plugins.themes.academic_pro.article.details##

References

  1. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J.2005;149(2):209-16.
  2. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola V-P, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J.2006;27(22):2725-36.
  3. Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E, et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). Intensive Care Med. 2011;37(4):619-26.
  4. Greene SJ, Fonarow GC, Solomon SD, Subacius H, Maggioni AP, Böhm M, et al. Global variation in clinical profile, management, and post- discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial. Eur J Heart Fail.2015;17(6):591-600
  5. Lee SE, Cho H-J, Lee H-Y, Yang H-M, Choi J-O, Jeon E-S, et al. A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry. Eur J Heart Fail. 2014;16(6):700-8.
  6. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More « malignant » than cancer Five-year survival following a first admission for heart failure. Eur J Heart Fail.2001;3(3):315-22.
  7. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation.2009;119(3):e21-181
  8. Boulay F, Berthier F, Sisteron 0, Gendreike Y, Gibelin P. Seasonal variation in chronic heart failure hospitalizations and mortality in France. Circulation 1999;100:280-6.
  9. Stewart S, Macintyre K, Macleod MM, Bailey EM, Capewell S, and Mc MurrayJJ. Trends in hospitalization for heart failure in Scotland, 1990-1996.An epidemic that has reached its peak? Eur Heart J 2001;22:209-17.
  10. Haldeman GA, Croft GB, Giles WH, Rashidee A. Hospitalization of patients with heart failure; national hospital discharge survey 1985-1995. Am Heart J 1999; 137:352-60.
  11. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA2003;290(19):2581-2587
  12. Agrinier N, Thilly N, Briançon S, Juillière Y, Mertes P-M, Villemot J-P, et al. Prognostic factors associated with 15-year mortality in patients with hospitalized systolic HF: Results of the observational community-based EPICAL cohort study. Int J Cardiol.2017;228:940-7
  13. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22(4 Suppl A):6A- 13A
  14. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. The Lancet.1999;353(9146):9-13.
  15. Bourassa MG, Gurné O, Bangdiwala SI, Ghali JK, Young JB, Rousseau M, et al. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol. 1993;22(4 Suppl A):14A-9A.
  16. Tribouilloy C, Rusinaru D, Mahjoub H et al. Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study. Heart 2008;94(11):1450-1455.
  17. Opasich C, Tavazzi L, Lucci D . Comparison of one-year outcome in women versus men with chronic congestive heart failure. Am J Cardiol 2000;86(3):353-357.
  18. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J 2002;23(23):1861-1866.
  19. MacIntyre K, Capewell S, Stewart S . Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000;102(10):1126-113167.
  20. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC).The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012;33(14):1750-1757.
  21. Cohn JN, Johnson GR, Shabetai R. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The VHeFT VA Cooperative Studies Group. Circulation 1993;87(6 Suppl):VI5-16.
  22. Wedel H, McMurray JJV, Lindberg M, Wikstrand J, Cleland JGF, Cornel JH, et al. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin -Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. Eur J Heart Fail.2009;11(3):281-91.
  23. Gudina EK, Ali K, Workicho A. Hyponatremia in patients hospitalized with heart failure: a condition often overlooked in low-income settings. Int J Gen Med. 2016; 9:267-73.
  24. McClellan WM. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population based study. 2002.
  25. Cohn JN, Johnson GR, Shabetai R . Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The VHeFT VA Cooperative Studies Group. Circulation 1993;87(6 Suppl):VI5-16.
  26. Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JGF, Massie BM, Rydén L. Mode of death in heart failure: findings from the ATLAS trial. Heart. 2003;89(1):42-8.
  27. Solomon SD, Anavekar N, Skali H, McMurray JJV, Swedberg K, Yusuf S, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation.2005;112(24):3738- 44.
  28. Saito M, Negishi K, Eskandari M, Huynh Q, Hawson J, Moore A, et al. Association of left ventricular strain with 30-day mortality and readmission in patients with heart failure. J Am Soc Echocardiogr.2015;28(6):652-66.
  29. Damy T, Viallet C, Lairez O, Deswarte G, Paulino A, Maison P, et al. Comparison of four right ventricular systolic echocardiographic parameters to predict adverse outcomes in chronic heart failure. Eur J Heart Fail. 2009;11(9):818-24.
  30. Bursi F, McNallan SM, Redfield MM, Nkomo VT, Lam CSP, Weston SA, et al. Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol.2012;59(3):222-31.
  31. Addetia K, Michel C, Holcroft CA, Sheppard R, Rudski LG. Early improvement in serial echocardiographic studies in heart failure patients predicts long term survival-a pilot study. J Card Fail. 2015;21(6):470-
  32. van den Berge JC, Akkerhuis MK, Constantinescu AA, Kors JA, van Domburg RT, Deckers JW. Temporal trends in long-term mortality of patients with acute heart failure: Data from 1985-2008. Int J Cardiol.2016;224:456-60.
  33. Goda A, Yamashita T, Suzuki S, Ohtsuka T, Uejima T, Oikawa Y, et al. Heart failure with preserved versus reduced left ventricular systolic function: a prospective cohort of Shinken Database 2004-2005. J Cardiol. 2010;55(1):108-16.
  34. Iacoviello M, Puzzovivo A, Guida P, Forleo C, Monitillo F, Catanzaro R, et al. Independent role of left ventricular global longitudinal strain in predicting prognosis of chronic heart failure patients. Echocardiography.2013;30(7):803-11.